Publications by authors named "T Steinmetz"

Thrombotic microangiopathy is a severe complication of renal transplantation. Little is known about risk factors, incidence of autoantibodies against complement components, and prognosis. Clinical and laboratory data were retrospectively collected for 13 patients diagnosed with post-transplant thrombotic microangiopathy (PT-TMA) in 2011-2018.

View Article and Find Full Text PDF

Introduction: The prevalence of preexisting obstructive coronary artery disease (CAD) and the occurrence of anginal chest pain as a presenting symptom in patients with light-chain (AL) and transthyretin (ATTR) cardiac amyloidosis (CA) are undetermined.

Methods: A single-center analysis of clinical, laboratory, imaging, and angiographic characteristics of CA cohort was performed.

Results: Included were 98 CA patients (43 AL, 47 wtATTR, 8 mutant ATTR).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between abnormal cholesterol levels and cardiovascular issues in kidney transplant recipients (KTR), focusing on Major Adverse Cardiovascular Events (MACE) and mortality rates.
  • It analyzed data from 737 KTR patients over a median follow-up of nearly eight years, finding that high LDL-C levels and a high LDL-C/HDL-C ratio significantly predicted an increased risk of MACE.
  • The researchers conclude that monitoring and improving cholesterol profiles, particularly the LDL-C/HDL-C ratio, is crucial for managing cardiovascular risk in this vulnerable population.
View Article and Find Full Text PDF

Background: Tacrolimus blood level variability is associated with reduced graft survival among kidney transplant recipients. To date, no practical approach for reducing variability has been validated. We defined specific tacrolimus blood level patterns correlated with variability and evaluated their independent association with reduced graft survival.

View Article and Find Full Text PDF

Since the late 1980s, patient registries have played a pivotal role in the elucidation of rare diseases. For myelodysplastic syndromes (MDS), they revealed the disease actually to be diverse rather than rare. Registry data enabled the definition of various MDS subtypes and prognostic scores tailoring therapy.

View Article and Find Full Text PDF